MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CUE — Cue Biopharma, Inc.
NasdaqCue Biopharma, Inc.
$25.57
+0.32(+1.27%)
- O
- 25.60
- H
- 25.92
- L
- 24.67
- V
- 156.83K
⏱️ End-of-day dataAs of Oct 2, 2026
CUE — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | 16,379.00 | 27,136.00 | 11,701.00 | 27,492.00 | 13,136.00 | 22,459.00 |
| Accounts Receivable | 5,351.00 | 5,546.00 | 387.00 | 532.00 | 0.00 | 945.00 |
| Prepaid Assets | 1,062.00 | 1,093.00 | 1,747.00 | 470.00 | 912.00 | 929.00 |
| Other Current Assets | 1,701.00 | 1,309.00 | 3,114.00 | 2,350.00 | 1,883.00 | 805.00 |
| Total Current Assets | 26,392.00 | 36,983.00 | 25,819.00 | 30,844.00 | 15,931.00 | 25,138.00 |
| Properties | 6,829.00 | 7,585.00 | 8,113.00 | 9,053.00 | 7,523.00 | 8,155.00 |
| Machinery Furniture Equipment | 396.00 | 275.00 | 275.00 | 275.00 | 248.00 | 248.00 |
| Leases | 118.00 | 118.00 | 118.00 | 118.00 | 118.00 | 118.00 |
| Accumulated Depreciation | -3,737.00 | -3,663.00 | -3,597.00 | -3,874.00 | -3,777.00 | -3,680.00 |
| Other Non Current Assets | 244.00 | 248.00 | 249.00 | 2,335.00 | 255.00 | 257.00 |
| Total Non Current Assets | 4,485.00 | 5,229.00 | 5,825.00 | 9,863.00 | 6,323.00 | 7,053.00 |
| Total Assets | 30,877.00 | 42,212.00 | 31,644.00 | 40,707.00 | 22,254.00 | 32,191.00 |
| Accounts Payable | 3,327.00 | 3,948.00 | 2,348.00 | 3,627.00 | 3,784.00 | 2,823.00 |
| Accrued Expenses | 752.00 | 828.00 | 625.00 | 1,316.00 | 1,620.00 | 1,096.00 |
| Short Term Debt | 1,562.00 | 1,911.00 | 3,489.00 | 4,530.00 | 6,949.00 | 7,873.00 |
| Deferred Revenue | 0.00 | 5,335.00 | 7,816.00 | 9,579.00 | 0.00 | 85.00 |
| Pensions | 747.00 | 783.00 | 1,246.00 | 202.00 | 2,610.00 | 1,812.00 |
| Total Current Liabilities | 7,391.00 | 13,494.00 | 15,524.00 | 19,254.00 | 15,498.00 | 13,689.00 |
| Long Term Debt | 1,878.00 | 2,286.00 | 2,684.00 | 3,104.00 | 176.00 | 1,003.00 |
| Total Non Current Liabilities | 1,878.00 | 2,286.00 | 2,874.00 | 3,294.00 | 176.00 | 1,003.00 |
| Total Liabilities | 9,269.00 | 15,780.00 | 18,398.00 | 22,548.00 | 15,674.00 | 14,692.00 |
| Common Stock | 3.00 | 97.00 | 78.00 | 76.00 | 62.00 | 62.00 |
| Retained Earnings | -373,644.00 | -368,466.00 | -370,051.00 | -362,603.00 | -354,121.00 | -341,864.00 |
| Total Shareholders Equity | 21,608.00 | 26,432.00 | 13,246.00 | 18,159.00 | 6,580.00 | 17,499.00 |
| Additional Paid In Capital | 395,249.00 | 394,801.00 | 383,218.00 | 380,686.00 | 360,639.00 | 359,301.00 |
| Other Short Term Investments | N/A | N/A | 6,971.00 | N/A | N/A | N/A |
| Provision For Risks And Charges | N/A | N/A | 190.00 | 190.00 | N/A | N/A |
| Other Shareholders Equity | N/A | N/A | 1.00 | N/A | N/A | N/A |